Tag: Eli Lilly

7/24/2015

Taking stock of new Alzheimer’s drug coverage: A “landmark breakthrough” that offers no “clinically apparent benefit”

Blog

Opinions on other issues in news, journals, PR, advertising, marketing

@HealthNewsRevu

Retweet on TwitterHealthNewsReview.org Retweeted
MedMtgNewsMedical Meeting News@MedMtgNews·

Monday at #ADA2021, an infectious disease epidemiologist, a journalist, and a researcher shared perspectives on communication of risk in the era of COVID-19: http://ow.ly/ROfR30rMeE7 @AstleyCM @garyschwitzer @berthahidalgo @ADA_DiabetesPro

Reply on Twitter 1409881869332713473Retweet on Twitter 14098818693327134736Like on Twitter 14098818693327134732Twitter 1409881869332713473
Retweet on TwitterHealthNewsReview.org Retweeted
barttels2barttels@barttels2·

Shoutouts to @susan_bewley @drkevinknopf @MichaelBaum11 in this call for more than fawning coverage from press releases for these kinds of stories.

Also, linked history inside goes back 5 years just on Grail apparently trying to become Holy Grail. https://twitter.com/garyschwitzer/status/1408849696416841731

Reply on Twitter 1408881688650817537Retweet on Twitter 14088816886508175373Like on Twitter 14088816886508175375Twitter 1408881688650817537
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

Here we go again w/more news about “Blood test finds 50 types of cancer.” And here we see again what’s missing from most such news stories. https://www.healthnewsreview.org/2021/06/blood-test-finds-50-types-of-cancer-weve-been-down-this-path-before/

Reply on Twitter 1408859965557809152Retweet on Twitter 14088599655578091523Like on Twitter 14088599655578091522Twitter 1408859965557809152
View More

Categories

View More

Tags